Cash on Hand for Henry Schein (HSIC)
According to Henry Schein's latest reported financial statements, the company's latest reported cash and short-term investments is $156.00M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
HSIC
Currently viewingCash on HandSwitch metric
Latest period
$156.00M
YoY change
+27.9%
5Y CAGR
-18.0%
Peak year (2009)
$471.15M
Latest annual
$156.00M
Cash on Hand history chart for Henry Schein (HSIC) from 1994 to 2025
Cash on Hand history table for Henry Schein (HSIC) from 1994 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $156.00M | +27.9% | ||
| 2024 | $122.00M | -28.7% | ||
| 2023 | $171.00M | +46.2% | ||
| 2022 | $117.00M | -0.8% | ||
| 2021 | $118.00M | -72.0% | ||
| 2020 | $421.19M | +297.0% | ||
| 2019 | $106.10M | +86.5% | ||
| 2018 | $56.88M | -67.4% | ||
| 2017 | $174.66M | +180.0% | ||
| 2016 | $62.38M | -13.5% | ||
| 2015 | $72.09M | -19.4% | ||
| 2014 | $89.47M | -52.6% | ||
| 2013 | $188.62M | +54.5% | ||
| 2012 | $122.08M | -17.1% | ||
| 2011 | $147.28M | -2.0% | ||
| 2010 | $150.35M | -68.1% | ||
| 2009 | $471.15M | +27.5% | ||
| 2008 | $369.57M | +48.7% | ||
| 2007 | $248.59M | -16.2% | ||
| 2006 | $296.65M | -11.4% | ||
| 2005 | $334.69M | +79.3% | ||
| 2004 | $186.62M | +16.4% | ||
| 2003 | $160.36M | -30.8% | ||
| 2002 | $231.86M | +19.9% | ||
| 2001 | $193.37M | +231.3% | ||
| 2000 | $58.36M | +124.5% | ||
| 1999 | $26.00M | -7.8% | ||
| 1998 | $28.20M | +139.0% | ||
| 1997 | $11.80M | -74.2% | ||
| 1996 | $45.80M | +502.6% | ||
| 1995 | $7.60M | +68.9% | ||
| 1994 | $4.50M | — |
Cash on Hand values are taken from Henry Schein's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Henry Schein (HSIC) reported cash and short-term investments of $156.00M – grew 27.9% year-over-year.
Through 2020–2025 (5 years), Henry Schein cash and short-term investments delivered a -18.0% annualised rate; with a net decline across the window.
Between 2009 and 2025, Henry Schein cash and short-term investments plunged 66.9%, falling from $471.15M to $156.00M.
The dataset's maximum cash and short-term investments sits at $471.15M (2009); the minimum reading of $4.50M dates to 1994.
Among 8 Healthcare peers, Henry Schein (HSIC) ranks 9th; the peer median for cash and short-term investments is $11.85B.
Henry Schein Cash on Hand by Year
Henry Schein Cash on Hand 2025: $156.00M
Henry Schein cash and short-term investments in 2025 was $156.00M, grew 27.9% from 2024.
Henry Schein Cash on Hand 2024: $122.00M
Henry Schein cash and short-term investments in 2024 was $122.00M, declined 28.7% below 2023.
Henry Schein Cash on Hand 2023: $171.00M
Henry Schein cash and short-term investments in 2023 was $171.00M, surged 46.2% from 2022.
Henry Schein Cash on Hand 2022: $117.00M
Henry Schein cash and short-term investments in 2022 was $117.00M, edged down 0.8% below 2021.
Henry Schein Cash on Hand 2021: $118.00M
Henry Schein cash and short-term investments in 2021 was $118.00M.
See more financial history for Henry Schein (HSIC).
Sector peers — Cash on Hand
Companies in the same sector as Henry Schein, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Henry Schein's cash and short-term investments?
- Latest reported cash and short-term investments for Henry Schein (HSIC) is $156.00M (period ending December 27, 2025).
How has Henry Schein cash and short-term investments changed year-over-year?
- Henry Schein (HSIC) cash and short-term investments changed +27.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Henry Schein cash and short-term investments?
- Henry Schein (HSIC) cash and short-term investments compound annual growth rate is -18.0% over the most recent 5 years available.
When did Henry Schein cash and short-term investments hit its highest annual value?
- Henry Schein cash and short-term investments reached its highest annual value of $471.15M in 2009.
What was Henry Schein cash and short-term investments in 2024?
- Henry Schein (HSIC) cash and short-term investments in 2024 was $122.00M.
What was Henry Schein cash and short-term investments in 2025?
- Henry Schein (HSIC) cash and short-term investments in 2025 was $156.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
HSIC Overview
Company profile, financial tools, and key metrics
HSIC Revenue Counter
Earns $418.06 every second. See per minute, hour, and day.
HSIC Earnings Counter
Earns $12.62 per second net profit. See per minute, hour, and day.
HSIC Economic Scale
Exceeds Equatorial Guinea's GDP. Compare with world economies.
HSIC What If Invested
What if you had invested $1,000? See historical returns from any date.
HSIC How It Makes Money
Discover visual breakdown of $13.18B in revenue — where it comes from and where it goes.
HSIC Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HSIC Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HSIC Daily Price Character
Balanced · 50.2% historical win rate (green days). Streaks & record days.
HSIC Buybacks
9.51% TTM buyback yield. Shareholder yield & SBC comparison.
HSIC Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.